A Study to Learn How Well ATM-AVI With or Without Metronidazole Works Compared to Best Available Therapy in Treating Serious Infections Caused by Gram-Negative Bacteria that Produce a Protein Called Metalloβ-Lactamase (MBL)
A Prospective, Randomized, Open-Label, Comparative Study to Assess the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) and Best Available Therapy for the Treatment of Serious Infections due to Multi-Drug Resistant Gram-Negative Bacteria Producing Metallo-β-Lactamase (MBL)
Category & Conditions: Infections and Infectious Diseases
Medicine: aztreonam-avibactam (PF-06947387)
ClinicalTrials.gov Identifier (NCT): https://clinicaltrials.gov/study/NCT03580044?term=C3601009&rank=1
Protocol ID: C3601009
PrintDownloadOpen Plain Language Summary Result: Click here